In human hepatocellular carcinoma cells, miR-221-3p was found to control cyclin-dependent kinase inhibitor 1B (p27Kip1) and cyclin-dependent kinase inhibitor 1C (p57Kip2) expression (Fornari et al. 2008). Here, CDKN1B is linked to hepatocellular carcinoma.